MENU
+Compare
BHVN
Stock ticker: NYSE
AS OF
Dec 20, 04:59 PM (EDT)
Price
$36.17
Change
+$0.83 (+2.35%)
Capitalization
3.67B

BHVN Biohaven Ltd Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical drugs

Industry Biotechnology
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for BHVN with price predictions
Dec 20, 2024

BHVN in downward trend: 10-day moving average crossed below 50-day moving average on November 21, 2024

The 10-day moving average for BHVN crossed bearishly below the 50-day moving average on November 21, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 03, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on BHVN as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BHVN moved below its 50-day moving average on November 15, 2024 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHVN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BHVN entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BHVN's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

BHVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BHVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.601) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). BHVN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (255.281).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BHVN is expected to report earnings to fall 8.05% to -160 cents per share on March 20

Biohaven Ltd BHVN Stock Earnings Reports
Q4'24
Est.
$-1.60
Q3'24
Missed
by $0.04
Q2'24
Missed
by $1.72
Q1'24
Missed
by $0.65
Q4'23
Missed
by $0.40
The last earnings report on November 12 showed earnings per share of -174 cents, missing the estimate of -170 cents. With 3.23M shares outstanding, the current market capitalization sits at 3.67B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLBFX34.410.26
+0.76%
American Funds American Balanced R5
WAYEX17.790.08
+0.45%
Waycross Managed Risk Equity Fund
PMFRX11.330.04
+0.35%
Pioneer Multi-Asset Income R
FGFAX35.48-0.08
-0.22%
Federated Hermes International Leaders A
HAMVX25.75-0.86
-3.22%
Harbor Mid Cap Value Instl

BHVN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with XENE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+2.60%
XENE - BHVN
44%
Loosely correlated
-0.69%
VCYT - BHVN
43%
Loosely correlated
+4.66%
ACLX - BHVN
42%
Loosely correlated
+0.44%
APGE - BHVN
40%
Loosely correlated
+1.47%
SYRE - BHVN
39%
Loosely correlated
+3.16%
More